A Comparison of Oral Misoprostol and Vaginal Misoprostol for Cervical Ripening and Induction of Labor
| Status: | Recruiting |
|---|---|
| Conditions: | Women's Studies |
| Therapuetic Areas: | Reproductive |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/15/2019 |
| Start Date: | November 1, 2017 |
| End Date: | January 2021 |
| Contact: | Andrew Shoemaker, MD |
| Email: | ashoemaker1@pennstatehealth.psu.edu |
| Phone: | 717-531-8521 |
The purpose of this study is to study if misoprostol administered orally is at least as
effective as misoprostol administered vaginally for cervical ripening and the induction of
labor. The main purpose is to show that oral misoprostol administration is non-inferior to
vaginal misoprostol administration with respect to the time interval from misoprostol
administration to onset of active phase of labor. The study is a non-inferiority, prospective
randomized controlled trial comparing oral misoprostol given as 25 mcg every 2 hours versus
vaginal misoprostol given as 25 mcg every 4 hours.
effective as misoprostol administered vaginally for cervical ripening and the induction of
labor. The main purpose is to show that oral misoprostol administration is non-inferior to
vaginal misoprostol administration with respect to the time interval from misoprostol
administration to onset of active phase of labor. The study is a non-inferiority, prospective
randomized controlled trial comparing oral misoprostol given as 25 mcg every 2 hours versus
vaginal misoprostol given as 25 mcg every 4 hours.
Inclusion Criteria:
1. Pregnant Female Patients greater than or equal to 18 years of age
2. Induction of labor for a single live intrauterine pregnancy
3. Greater than or equal to 37 weeks gestational age
4. Cephalic presentation
5. 20 minute reassuring fetal heart rate (reactive nonstress test (NST))
6. Bishop score based on sterile vaginal exam of less than or equal to 6, for which the
cervical dilation is less than or equal to 2 cm.
7. Equal to 3 or less uterine contractions over 10 minutes
Exclusion Criteria:
1. Previous uterine scar
2. Contraindication to vaginal delivery
3. Patients with preeclampsia
4. Grand multiparty - greater than or equal to 5 live births or stillbirths
5. Premature rupture of membranes
6. Suspected intrauterine growth restriction
7. Fetal anomalies
8. Contraindication to misoprostol (history of allergy to prostaglandins, glaucoma)
We found this trial at
1
site
Click here to add this to my saved trials
